Combinación…..
•
Con fármacos anti-diana:
–
Enzalutamide and
Niraparib
in the Treatment of Metastatic
Castrate-Resistant Prostate Cancer (CRPC)
–
Crizotinib
in Combination With Enzalutamide in Metastatic
Castration-resistant Prostate Cancer
A Study of
ZEN003694
in Combination With Enzalutamide in
–
Patients With Metastatic Castration-Resistant Prostate Cancer
–
Study of TGF-β Receptor Inhibitor
Galunisertib
(LY2157299) and
E l t id i M t t ti C t ti
i t t P t t C
nza u am e n e as a c as ra on-res s an ros a e ancer
–
Enzalutamide With and Without
Ribociclib
for Metastatic,
Castrate-Resistant, Chemotherapy-Naive Prostate Cancer that
R t i RB E i
e a ns
xpress on
–
BI836845
Plus Enzalutamide in Castrate Resistant Prostate Cancer
